Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
It has been investigated in phase I clinical trials for the treatment of gastrointestinal ulcers as well as tendon and muscle injuries
- People with significant liver disease (the 9-month monkey toxicology study showed dose-dependent periportal vacuolation in hepatocytes that the FDA flagged as a possible safety signal)
Preservation occurs through the inclusion of 0.9% benzyl alcohol, which inhibits bacterial reproduction by disrupting microbial cell membrane activity
PMID 17991639
Because they influence different pathways, researchers often investigate how each compound behaves independently before comparing findings
US$ 20.77
US$ 20.09
US$ 20.14
US$ 23.51
